Wk16 CER: Vaccine data CER analysis

H1: your evidence task

Write a CER from the original graph V1 and its complete D1 table. Name two exact data points, explain a possible memory mechanism and state a meaningful limitation.

The curve is constructed for practice. It is not a vaccine trial, a participant record or measured class data. No person, vaccine product, sample size or health outcome is represented.

Use the May 3 principle about binding, memory and limits. Actual completion of that model is not assumed. Its model ticks and tokens are not the units or source of today’s new curve.

E1: from cells to a possible explanation

Vaccination can prepare an immune response to a target. Selected B cells can expand and develop into plasma cells that release antibodies. Some responding cells become memory B cells.

A later encounter can activate memory cells and lead to quicker antibody output. This takes biological steps; it is not instant recognition followed by instant protection. Plasma cells make antibodies, while memory B cells support later responses.

An antibody curve measures or represents antibody level, not memory-cell number. A higher second peak can be consistent with memory, but the curve alone cannot prove that memory caused it.

Antibodies can help protect when they block a harmful process or support other defenses. Protection also depends on the target, response quality and person. A high level does not guarantee lifelong protection.

D1: complete constructed vaccine curve

V1 uses days since the first fictional dose on the horizontal axis and antibody level in arbitrary units (AU) on the vertical axis. AU here has no conversion to an actual blood concentration.

Complete paired table, written as day:AU: 0:0; 7:2; 14:10; 21:6; 28:3; 35:30; 42:18; 49:10; 56:7; 84:4; 180:1. All eleven values are authored teaching points.

Fictional dose events occur at day 0 and day 28, just after the listed value at each day. The day-28 point is before the second dose. No amount or vaccine formulation is supplied.

Use days 0–28 as the first-response window and days 28–56 as the repeat-response window. Day 84 and day 180 extend the later decline. Connections between points guide the eye; they are not added observations.

For elapsed time to a sampled peak, subtract the relevant dose day from the peak day. Compare the two elapsed times, not the raw calendar positions. Do not assume the true peak occurred exactly at a sampled point.

Low starting value, first sampled peak and higher second sampled peak are three features to identify before drafting. Cite each selected point with its day, value, units and D1 identifier.

E2: limits that change the conclusion

No memory cells, infections, symptoms, neutralization results, control group or individual responses were measured in D1. The graph cannot establish vaccine effectiveness, a person’s protection or the duration of memory.

The later decline describes waning represented antibody level. It does not prove memory vanished. It also does not prove that enough protection remains. Both stronger conclusions would require additional evidence.

A useful limitation names what is missing and its consequence. For example: without illness outcomes and a suitable comparison, this curve cannot estimate how much disease a vaccine prevents.

In actual research, a graph’s methods, assay units, sample size, uncertainty and comparison groups matter. Ask for these with the actual assigned dataset. Do not invent them for the practice curve.

R1: a complete CER and review route

Claim: explain how vaccines can prepare immunity, while labeling D1 as an illustration. Evidence: write two separate entries, each giving one exact day and AU value. Select one point from each response window.

Reasoning: connect target exposure to B-cell activation, expansion, plasma-cell antibody release and a possible memory response. Distinguish the source-supported mechanism from what the constructed curve itself demonstrates.

Limitation: name at least one missing input and explain which conclusion it prevents. Keep claim, both evidence entries, reasoning and limitation in the same written CER.

Peer route: ask an available partner to find your two exact points and underline the cell mechanism. Record the actual comment. Then show one sentence before and after revision, with a reason.

Solo route: apply both checks yourself. Check A: are both day/value pairs accurate and labeled? Check B: does the reasoning name cells and avoid proving protection? Record findings and revise one sentence.

If returning after an absence or break, begin with the first unfinished CER part. A shorter three-sentence start still needs both exact evidence entries and the limitation. Use D1 until actual assigned data are available.

Q1: self-check and extension

Self-check: in a separate hypothetical record, blood antibody level falls by about six months after vaccination. No memory-cell or illness measurements are given. A student says the vaccine has stopped working. Is that established?

After answering, check your reasoning against E1 and E2: list what the record measured and what it did not, then decide whether a claim of failure or of preserved protection needs one of the missing measurements. Explain one further kind of evidence needed.

For the optional extension, compare antibody maintenance with memory. CDC describes tetanus as a toxin-caused illness. Antitoxin can act on unbound toxin, but cannot undo toxin already bound to nerve endings.

CDC’s current adult guidance lists tetanus vaccination every ten years to maintain protection. Wound-related care and individual recommendations require separate clinical guidance. Do not use this classroom graph to set anyone’s dose schedule.

CDC also explains that some vaccine responses last longer than others and antibody levels can fall. Propose why maintaining antibodies may matter even when memory is present. Explain why different diseases can need different schedules, without promising lifelong protection from any series.

P1: real work and next steps

For May 4, confirm which Lesson 3.2 antibody-data or Activity 3.2.2 analysis task is assigned. Obtain its actual graph, units, instructions and required proof. Follow that task's directions separately and use evidence from work you actually do.

Activity 3.2.2 Immune Defense includes cell research, bacterial-versus-viral comparisons, teacher-led origami and a ten-term concept map. Its assigned video, tours, template, full instructions and journal pages 7–8 remain separate materials.

Keep any unfinished May 3 model, official check-in and earlier 3.2.1 organizer/model/journal work on your checklist. Today’s CER does not establish that those were done. Preserve the requested completion screenshot or note only after genuine work.

The May 3–7 checklist includes evidence through 3.2.3 Going Un-Viral, the Immune defense model, transmission, a plaque assay and eye dissection. Obtain the teacher-posted packet and assigned Khan immune resources when absent.

Ask your teacher which remaining unit tasks and deadlines apply, including any debate or analysis work; do not treat this CER as all weekly work.

No homework is due before this class. May 5 has 25-minute Submit tracker and evidence preparation in Class Records, separate from today’s eighty minutes. The next lesson concerns pathogen transmission and antiviral action.

Save the complete CER with the annotated graph and review/revision notes. Use the original practice, actual data/official task, peer or solo review, tracker and submission checks to identify a specific next action; describe only work you actually do. Never invent a measurement, partner comment or upload.

Predict and orient

Answer both warmups: what mechanism could explain a higher repeat peak, and why might a blood antibody level miss part of protection? Label V1 axes, doses and three key features.

Use the low starting point and both sampled peaks. Say could explain, not proves.

Compare like intervals

Mark both response windows and calculate elapsed dose-to-sampled-peak time for each. Label memory-cell involvement as an inference, not a measured curve.

Use D1’s subtraction rule and M1. Keep days and AU distinct.

Write the full CER

Write the claim, two separate exact D1 evidence entries and reasoning naming memory B cells and plasma cells.

Cite day and AU for both points. Explain how vaccines can prepare immunity without calling D1 a real trial.

Add the limitation

Name one missing input and the conclusion it prevents. Answer Q1’s six-month self-check.

Use E2 to decide what a lower antibody level alone can and cannot establish.

Review and revise

Use actual peer feedback or both R1 solo checks. Record the route and show a before/after sentence with a reason.

Do not invent a peer. Revise unsupported proof, instant-response or lifetime language.

Optional booster comparison

Use Q1’s tetanus and vaccine-duration facts to propose why antibody maintenance and memory can matter differently across diseases.

Do not recommend an individual dose or infer a schedule from D1. Finish the core CER first.

Save and carry forward

Keep all five CER parts, graph annotations and revision in the report. Use P1 to identify what you checked and anything you need, then prepare for the next lesson.

Use the supplied practice while you ask for missing actual data or access.